gpat3 Search Results


94
Genecopoeia gpat3
Gpat3, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gpat3/Promoter+reporter+clone+for+Human+GPAT3/pm38948063-60-4-27
Average 94 stars, based on 1 article reviews
gpat3 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

93
Proteintech glycerol 3 phosphate acyltransferase 9 gpat3
Glycerol 3 Phosphate Acyltransferase 9 Gpat3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gpat3/AGPAT9+Antibody/pm40157624-98-53-58
Average 93 stars, based on 1 article reviews
glycerol 3 phosphate acyltransferase 9 gpat3 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
OriGene pla assay origene gpat3 mycflag pcmv6entry pcmv6 entry mouse gpat3myc flag co ip
Pla Assay Origene Gpat3 Mycflag Pcmv6entry Pcmv6 Entry Mouse Gpat3myc Flag Co Ip, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gpat3/Gpat3+(NM_172715)+Mouse+Tagged+ORF+Clone/pmc05647143__NIHMS907566___supplement-131-40-42
Average 90 stars, based on 1 article reviews
pla assay origene gpat3 mycflag pcmv6entry pcmv6 entry mouse gpat3myc flag co ip - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Atlas Antibodies agpat9
Agpat9, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gpat3/Anti-GPAT3/pm34315727-97-9-12
Average 90 stars, based on 1 article reviews
agpat9 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
OriGene gpat3
Gpat3, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gpat3/Gpat3+(NM_001025670)+Rat+Untagged+Clone/pmc02882735-69-3-27
Average 90 stars, based on 1 article reviews
gpat3 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

86
Thermo Fisher gene exp gpat3 hs00262010 m1
Gene Exp Gpat3 Hs00262010 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gpat3/Gene+Exp%2E+GPAT3%2C+Hs00262010_m1/pmc04613657-175-50-85
Average 86 stars, based on 1 article reviews
gene exp gpat3 hs00262010 m1 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

90
CH Instruments protein levels of sirt1 and gpat3
Protein Levels Of Sirt1 And Gpat3, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gpat3/gpat3+protein/pm40422869-244-15-21
Average 90 stars, based on 1 article reviews
protein levels of sirt1 and gpat3 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma sirna against gpat3/4
Knocking down DGAT2 or GPAT4 restored normal LD morphology in CDS2-deficient cells. A, mRNA levels of DGAT1/2 and <t>GPAT3/4</t> upon CDS KD in HeLa cells. Two-tailed Student's t test was used: mean ± S.D. (error bars); n = 3; **, p < 0.01; ****, p < 0.0001. B, KD efficiency of DGAT1/2 and GPAT3/4 in HeLa cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01; ***, p < 0.001. Two different sequences (a and b) of siRNA against each gene were used. C, LD morphology when DGAT1/2 were knocked down in CDS-deficient HeLa cells. 200 μm oleate was added to cells to induce LD formation for 16 h. LDs were stained by BODIPY. Bars, 5 μm. D, distribution of LDs according to their sizes in C. LDs from ∼50 cells/cell type were used. E, LD morphology when DGAT3/4 were knocked down in CDS-deficient HeLa cells. 200 μm oleate was added to cells to induce LD formation for 16 h. LDs were stained by BODIPY. Bars, 5 μm. F, distribution of LDs according to their sizes in E. LDs from ∼50 cells/cell type were used. G, quantification of the diameters of the three largest LDs in each cell as shown in C and E. Two-tailed Student's t test was used: mean ± S.D.; n = 45 LDs from 15 cells for each cell type; *, p < 0.05; **, p < 0.01; ****, p < 0.0001; ns, no significance. H, total TAG level in CDS1/2 and DGAT1/2 KD cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01. I, total TAG level in CDS1/2 and GPAT3/4 KD cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01.
Sirna Against Gpat3/4, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gpat3/sirna+against+gpat3+4/pmc06851299-633-12-13
Average 90 stars, based on 1 article reviews
sirna against gpat3/4 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

94
Genecopoeia sgrna/cas9 all-in-one expression clones targeting gpat3
Knocking down DGAT2 or GPAT4 restored normal LD morphology in CDS2-deficient cells. A, mRNA levels of DGAT1/2 and <t>GPAT3/4</t> upon CDS KD in HeLa cells. Two-tailed Student's t test was used: mean ± S.D. (error bars); n = 3; **, p < 0.01; ****, p < 0.0001. B, KD efficiency of DGAT1/2 and GPAT3/4 in HeLa cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01; ***, p < 0.001. Two different sequences (a and b) of siRNA against each gene were used. C, LD morphology when DGAT1/2 were knocked down in CDS-deficient HeLa cells. 200 μm oleate was added to cells to induce LD formation for 16 h. LDs were stained by BODIPY. Bars, 5 μm. D, distribution of LDs according to their sizes in C. LDs from ∼50 cells/cell type were used. E, LD morphology when DGAT3/4 were knocked down in CDS-deficient HeLa cells. 200 μm oleate was added to cells to induce LD formation for 16 h. LDs were stained by BODIPY. Bars, 5 μm. F, distribution of LDs according to their sizes in E. LDs from ∼50 cells/cell type were used. G, quantification of the diameters of the three largest LDs in each cell as shown in C and E. Two-tailed Student's t test was used: mean ± S.D.; n = 45 LDs from 15 cells for each cell type; *, p < 0.05; **, p < 0.01; ****, p < 0.0001; ns, no significance. H, total TAG level in CDS1/2 and DGAT1/2 KD cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01. I, total TAG level in CDS1/2 and GPAT3/4 KD cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01.
Sgrna/Cas9 All In One Expression Clones Targeting Gpat3, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gpat3/sgRNA%2FCas9+all-in-one+expression+clones+targeting+GPAT3/custom%40hcp260234-cg04-3-10%4038948063
Average 94 stars, based on 1 article reviews
sgrna/cas9 all-in-one expression clones targeting gpat3 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Genecopoeia orf expression clone for gpat3
Knocking down DGAT2 or GPAT4 restored normal LD morphology in CDS2-deficient cells. A, mRNA levels of DGAT1/2 and <t>GPAT3/4</t> upon CDS KD in HeLa cells. Two-tailed Student's t test was used: mean ± S.D. (error bars); n = 3; **, p < 0.01; ****, p < 0.0001. B, KD efficiency of DGAT1/2 and GPAT3/4 in HeLa cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01; ***, p < 0.001. Two different sequences (a and b) of siRNA against each gene were used. C, LD morphology when DGAT1/2 were knocked down in CDS-deficient HeLa cells. 200 μm oleate was added to cells to induce LD formation for 16 h. LDs were stained by BODIPY. Bars, 5 μm. D, distribution of LDs according to their sizes in C. LDs from ∼50 cells/cell type were used. E, LD morphology when DGAT3/4 were knocked down in CDS-deficient HeLa cells. 200 μm oleate was added to cells to induce LD formation for 16 h. LDs were stained by BODIPY. Bars, 5 μm. F, distribution of LDs according to their sizes in E. LDs from ∼50 cells/cell type were used. G, quantification of the diameters of the three largest LDs in each cell as shown in C and E. Two-tailed Student's t test was used: mean ± S.D.; n = 45 LDs from 15 cells for each cell type; *, p < 0.05; **, p < 0.01; ****, p < 0.0001; ns, no significance. H, total TAG level in CDS1/2 and DGAT1/2 KD cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01. I, total TAG level in CDS1/2 and GPAT3/4 KD cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01.
Orf Expression Clone For Gpat3, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gpat3/ORF+expression+clone+for+GPAT3/custom%40ex-z1294-m35%4038948063
Average 94 stars, based on 1 article reviews
orf expression clone for gpat3 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

90
OriGene gpat3 mouse shrna lentiviral particle
Knocking down DGAT2 or GPAT4 restored normal LD morphology in CDS2-deficient cells. A, mRNA levels of DGAT1/2 and <t>GPAT3/4</t> upon CDS KD in HeLa cells. Two-tailed Student's t test was used: mean ± S.D. (error bars); n = 3; **, p < 0.01; ****, p < 0.0001. B, KD efficiency of DGAT1/2 and GPAT3/4 in HeLa cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01; ***, p < 0.001. Two different sequences (a and b) of siRNA against each gene were used. C, LD morphology when DGAT1/2 were knocked down in CDS-deficient HeLa cells. 200 μm oleate was added to cells to induce LD formation for 16 h. LDs were stained by BODIPY. Bars, 5 μm. D, distribution of LDs according to their sizes in C. LDs from ∼50 cells/cell type were used. E, LD morphology when DGAT3/4 were knocked down in CDS-deficient HeLa cells. 200 μm oleate was added to cells to induce LD formation for 16 h. LDs were stained by BODIPY. Bars, 5 μm. F, distribution of LDs according to their sizes in E. LDs from ∼50 cells/cell type were used. G, quantification of the diameters of the three largest LDs in each cell as shown in C and E. Two-tailed Student's t test was used: mean ± S.D.; n = 45 LDs from 15 cells for each cell type; *, p < 0.05; **, p < 0.01; ****, p < 0.0001; ns, no significance. H, total TAG level in CDS1/2 and DGAT1/2 KD cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01. I, total TAG level in CDS1/2 and GPAT3/4 KD cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01.
Gpat3 Mouse Shrna Lentiviral Particle, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gpat3/Gpat3+Mouse+shRNA+Lentiviral+Particle/origene___tl506938v
Average 90 stars, based on 1 article reviews
gpat3 mouse shrna lentiviral particle - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

N/A
AGPAT9 GFP tagged Homo sapiens 1 acylglycerol 3 phosphate O acyltransferase 9 AGPAT9 transcript variant 2
  Buy from Supplier

Image Search Results


Knocking down DGAT2 or GPAT4 restored normal LD morphology in CDS2-deficient cells. A, mRNA levels of DGAT1/2 and GPAT3/4 upon CDS KD in HeLa cells. Two-tailed Student's t test was used: mean ± S.D. (error bars); n = 3; **, p < 0.01; ****, p < 0.0001. B, KD efficiency of DGAT1/2 and GPAT3/4 in HeLa cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01; ***, p < 0.001. Two different sequences (a and b) of siRNA against each gene were used. C, LD morphology when DGAT1/2 were knocked down in CDS-deficient HeLa cells. 200 μm oleate was added to cells to induce LD formation for 16 h. LDs were stained by BODIPY. Bars, 5 μm. D, distribution of LDs according to their sizes in C. LDs from ∼50 cells/cell type were used. E, LD morphology when DGAT3/4 were knocked down in CDS-deficient HeLa cells. 200 μm oleate was added to cells to induce LD formation for 16 h. LDs were stained by BODIPY. Bars, 5 μm. F, distribution of LDs according to their sizes in E. LDs from ∼50 cells/cell type were used. G, quantification of the diameters of the three largest LDs in each cell as shown in C and E. Two-tailed Student's t test was used: mean ± S.D.; n = 45 LDs from 15 cells for each cell type; *, p < 0.05; **, p < 0.01; ****, p < 0.0001; ns, no significance. H, total TAG level in CDS1/2 and DGAT1/2 KD cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01. I, total TAG level in CDS1/2 and GPAT3/4 KD cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01.

Journal: The Journal of Biological Chemistry

Article Title: CDP-DAG synthase 1 and 2 regulate lipid droplet growth through distinct mechanisms

doi: 10.1074/jbc.RA119.009992

Figure Lengend Snippet: Knocking down DGAT2 or GPAT4 restored normal LD morphology in CDS2-deficient cells. A, mRNA levels of DGAT1/2 and GPAT3/4 upon CDS KD in HeLa cells. Two-tailed Student's t test was used: mean ± S.D. (error bars); n = 3; **, p < 0.01; ****, p < 0.0001. B, KD efficiency of DGAT1/2 and GPAT3/4 in HeLa cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01; ***, p < 0.001. Two different sequences (a and b) of siRNA against each gene were used. C, LD morphology when DGAT1/2 were knocked down in CDS-deficient HeLa cells. 200 μm oleate was added to cells to induce LD formation for 16 h. LDs were stained by BODIPY. Bars, 5 μm. D, distribution of LDs according to their sizes in C. LDs from ∼50 cells/cell type were used. E, LD morphology when DGAT3/4 were knocked down in CDS-deficient HeLa cells. 200 μm oleate was added to cells to induce LD formation for 16 h. LDs were stained by BODIPY. Bars, 5 μm. F, distribution of LDs according to their sizes in E. LDs from ∼50 cells/cell type were used. G, quantification of the diameters of the three largest LDs in each cell as shown in C and E. Two-tailed Student's t test was used: mean ± S.D.; n = 45 LDs from 15 cells for each cell type; *, p < 0.05; **, p < 0.01; ****, p < 0.0001; ns, no significance. H, total TAG level in CDS1/2 and DGAT1/2 KD cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01. I, total TAG level in CDS1/2 and GPAT3/4 KD cells. Two-tailed Student's t test was used: mean ± S.D.; n = 3; **, p < 0.01.

Article Snippet: Transient transfections of siRNA against CDS1/2 (Sigma-Aldrich), CIDEA/B/C (Shanghai GenePharma Co. Ltd.), GPAT3/4 (Shanghai GenePharma Co. Ltd.), and DGAT1/2 (Sigma-Aldrich) were carried out at 20 n m siRNA using Lipofectamine RNAiMAX reagent (Life Technologies) according to the manufacturer's protocol.

Techniques: Two Tailed Test, Staining

CDS2 deficiency promoted LD-association of GPAT4. A, localization of GPAT3 in CDS KD cells after incubation with 200 μm oleate for 16 h. Bars, 5 μm. B, quantification of LD sizes in cells transfected by GFP-GPAT3 upon CDS deficiency. Two-tailed Student's t test was used: mean, n = ∼200–300 LDs from ∼20 cells. *, p < 0.05; **, p < 0.01; ***, p < 0.001. C, distribution of LDs in cells transfected by GFP-GPAT3 upon CDS deficiency. LDs from ∼20 cells/cell type were used. D, localization of GPAT4 in CDS KD cells at the early stage of LD formation in CDS KD cells. 200 μm oleate was added to cells for the indicated time. Bars, 5 μm. Inset, bars, 1 μm. E, quantification of size (a and c) and distribution (b and d) of GPAT4-positive LDs at 3 and 8 h after adding oleate. Two-tailed Student's t test was used: mean; n = ∼200–350 LDs from ∼20 cells; ***, p < 0.001; ns, no significance. F, quantification of GPAT4-LD associations during LD growth upon CDS deficiency: mean ± S.E. (error bars); n = 20 cells. OA, oleate.

Journal: The Journal of Biological Chemistry

Article Title: CDP-DAG synthase 1 and 2 regulate lipid droplet growth through distinct mechanisms

doi: 10.1074/jbc.RA119.009992

Figure Lengend Snippet: CDS2 deficiency promoted LD-association of GPAT4. A, localization of GPAT3 in CDS KD cells after incubation with 200 μm oleate for 16 h. Bars, 5 μm. B, quantification of LD sizes in cells transfected by GFP-GPAT3 upon CDS deficiency. Two-tailed Student's t test was used: mean, n = ∼200–300 LDs from ∼20 cells. *, p < 0.05; **, p < 0.01; ***, p < 0.001. C, distribution of LDs in cells transfected by GFP-GPAT3 upon CDS deficiency. LDs from ∼20 cells/cell type were used. D, localization of GPAT4 in CDS KD cells at the early stage of LD formation in CDS KD cells. 200 μm oleate was added to cells for the indicated time. Bars, 5 μm. Inset, bars, 1 μm. E, quantification of size (a and c) and distribution (b and d) of GPAT4-positive LDs at 3 and 8 h after adding oleate. Two-tailed Student's t test was used: mean; n = ∼200–350 LDs from ∼20 cells; ***, p < 0.001; ns, no significance. F, quantification of GPAT4-LD associations during LD growth upon CDS deficiency: mean ± S.E. (error bars); n = 20 cells. OA, oleate.

Article Snippet: Transient transfections of siRNA against CDS1/2 (Sigma-Aldrich), CIDEA/B/C (Shanghai GenePharma Co. Ltd.), GPAT3/4 (Shanghai GenePharma Co. Ltd.), and DGAT1/2 (Sigma-Aldrich) were carried out at 20 n m siRNA using Lipofectamine RNAiMAX reagent (Life Technologies) according to the manufacturer's protocol.

Techniques: Incubation, Transfection, Two Tailed Test